focus -WSS

focus

author：Wikipedia 2025-09-28 23:29:36 - browse：749

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Problems with a popular proposal to regulate AI in health care

focus

hotspot

WSS

Pharma patents targeted by Biden in move to slash drug prices

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

What’s missing from the debate over nursing home staff minimums

Pharma patents targeted by Biden in move to slash drug prices

Cano Health’s bankruptcy is a warning for Medicare Advantage

SCOTUS to consider access to abortion pill mifepristone

hotspot

focus

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Devoted Health’s losses in Medicare Advantage persist

Affirmative action in medical school literally saved lives

Supreme Court wrestles with OxyContin maker's bankruptcy deal

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout LOUD: Venture capital, Gilead, and more M&A

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Radiology is caught between AI's potential and concern for patients

BioMarin wins approval for gene therapy to treat hemophilia A

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

leisure time

Congenital heart disease patients face new threat of heart failure

Supreme Court wrestles with OxyContin maker's bankruptcy deal

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

The Biogen Aduhelm mess could happen again

Patients' immediate access to test results puts radiologists in a bind

focus

hotspot

focus

entertainment